Precigen (PGEN) EBIT Margin: 2012-2025

Historic EBIT Margin for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to -1,180.05%.

  • Precigen's EBIT Margin rose 105101.00% to -1,180.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,860.15%, marking a year-over-year increase of 169112.00%. This contributed to the annual value of -3,440.23% for FY2024, which is 183769.00% down from last year.
  • According to the latest figures from Q3 2025, Precigen's EBIT Margin is -1,180.05%, which was up 68.20% from -3,710.75% recorded in Q2 2025.
  • Precigen's 5-year EBIT Margin high stood at -45.53% for Q3 2022, and its period low was -8,485.50% during Q2 2024.
  • Moreover, its 3-year median value for EBIT Margin was -2,231.06% (2024), whereas its average is -2,613.60%.
  • In the last 5 years, Precigen's EBIT Margin slumped by 729,025bps in 2024 and then spiked by 477,475bps in 2025.
  • Over the past 5 years, Precigen's EBIT Margin (Quarterly) stood at -593.70% in 2021, then slumped by 64,266bps to -1,236.36% in 2022, then crashed by 155,061bps to -2,786.97% in 2023, then soared by 39,067bps to -2,396.30% in 2024, then soared by 105,101bps to -1,180.05% in 2025.
  • Its EBIT Margin stands at -1,180.05% for Q3 2025, versus -3,710.75% for Q2 2025 and -1,685.01% for Q1 2025.